Research Article
Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas
Table 6
Univariate analysis of clinical features in gastroenteropancreatic neuroendocrine carcinoma patients with liver metastasis.
| Variables | Survival status | | valuesa | Death | Survival |
| Gender | | | 0.027 | 0.869 | Female | 11 | 3 | | | Male | 14 | 6 | | | Age (years) | | | 0.708 | 0.400 | ≤50 | 7 | 2 | | | >50 | 18 | 7 | | | ALT (U/L) | | | 1.231 | 0.267 | ≤40 | 19 | 8 | | | >40 | 6 | 1 | | | AST (U/L) | | | 1.614 | 0.204 | ≤40 | 16 | 8 | | | >40 | 9 | 1 | | | HB (G/L) | | | 0.740 | 0.390 | ≤110 | 4 | 3 | | | >110 | 21 | 6 | | | Albumin (G/L) | | | 0.235 | 0.628 | ≤35 | 6 | 1 | | | >35 | 19 | 8 | | | ALP (U/L) | | | 0.025 | 0.874 | ≤105 | 13 | 6 | | | >105 | 12 | 3 | | | GGT (U/L) | | | 0.652 | 0.419 | ≤50 | 10 | 7 | | | >50 | 15 | 2 | | | Location in liver | | | 0. 097 | 0.755 | Left | 3 | 7 | | | Right | 6 | 2 | | | Unknown | 16 | 0 | | | Diameter | | | 1.979 | 0.160 | ≤5 (cm) | 12 | 5 | | | >5 (cm) | 7 | 0 | | | Unknown | 6 | 4 | | | CA125 (μg/mL) | | | 0.426 | 0.514 | ≤35 | 21 | 8 | | | >35 | 3 | 1 | | | Unknown | 1 | 0 | | | CA19-9 (μg/mL) | | | 0.083 | 0.773 | ≤35 | 16 | 7 | | | >35 | 8 | 2 | | | Unknown | 1 | 0 | | | HbsAg | | | 0.008 | 0.927 | Positive | 4 | 1 | | | Negative | 21 | 8 | | | Treatment | | | 10.955 | 0.001 | Operation | 12 | 5 | | | Others | 13 | 4 | | | CK7 | | | 5.237 | 0.022 | Positive | 9 | 6 | | | Negative | 6 | 1 | | | Unknown | 10 | 2 | | |
|
|
ALT = alanine aminotransferase, AST = aspartate aminotransferase, HB = hemoglobin, ALP = alkaline phosphatase, GGT = γ-glutamyl transpeptidase, CA125 = carbohydrate antigen 125, CA19-9 = carbohydrate antigen 19-9, HbsAg = hepatitis B virus surface antigen. aKaplan–Meier survival curve and log-rank test. indicates . |